As of January 23, 2025, iSpecimen (ISPC) has a market cap of $2.204 million USD. According to our data, iSpecimen is ranked No.9178 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $2.20 M |
-13.75%
|
Dec 31, 2024 | $2.56 M |
-73.50%
|
Dec 29, 2023 | $9.65 M |
-63.56%
|
Dec 30, 2022 | $26.47 M |
-82.39%
|
Dec 31, 2021 | $0.15 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Bio-Rad Laboratories
BIO
|
$10.07 B |
1.804 B
|
USA
|
Illumina
ILMN
|
$22.26 B |
0.000 M
|
USA
|
Thermo Fisher Scientific
TMO
|
$219.78 B |
-0.008 M
|
USA
|
Agilent Technologies
A
|
$43.58 B |
0.000 M
|
USA
|
Qiagen
QGEN
|
$10.50 B |
0.000 M
|
Netherlands
|
Danaher
DHR
|
$176.37 B |
0.003 M
|
USA
|
Bruker
BRKR
|
$9.11 B |
0.000 M
|
USA
|
Waters Corporation
WAT
|
$24.25 B |
0.000 M
|
USA
|
Charles River Laboratories
CRL
|
$8.60 B |
-0.000 M
|
USA
|
Pacific Biosciences
PACB
|
$0.53 B |
-0.000 M
|
USA
|
10x Genomics
TXG
|
$1.97 B |
0.229 B
|
USA
|
Guardant Health
GH
|
$5.83 B |
0.000 M
|
USA
|
Adaptive Biotechnologies
ADPT
|
$1.18 B |
0.000 M
|
USA
|
NeoGenomics
NEO
|
$1.86 B |
0.000 M
|
USA
|
Market Cap | = | ISPC Stock Price | * | ISPC Shares Outstanding |
= | $2.29 | * | 0.96 M | |
= | $2.20 M |